BSBaptiste Sauterey

Baptiste Sauterey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Baptiste Sauterey has a total of 181 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development and validation of a predictive model of aromatase inhibitor–induced arthralgia among patients with early breast cancer

    by Pietro Lapidari, Maryam Lustberg, Julie Havas, Martina Pagliuca, Chayma Bousrih, Christelle Jouannaud, Marion Fournier, William Jacot, Laurence Vanlemmens, Kaderbhai Courèche, et al.

    Background: Aromatase inhibitor–induced arthralgia is common in patients with early-stage breast cancer who are on aromatase inhibitors, potentially compromising adherence and outcomes. We developed and validated prediction models for short-term and longer-term aromatase inhibitor–induced arthralgia. Methods: Postmenopausal patients with stage I to III breast cancer on adjuvant aromatase inhibitors in the Chronic Toxicities Related to Treatment in Patients With Localized Cancer (CANTO; NCT01993498) trial were included. The primary outcome was aromatase inhibitor–induced arthralgia (any-grade articular or muscular pain; Common Terminology Criteria for Adverse Events, version 4.0) at year 1 and year 4 cohort visits. Baseline clinical, behavioral, treatment-related, and patient-reported (European Organisation for Research and Treatment of Cancer Quality of Life Group Core Questionnaire, Hospital Anxiety and Depression Scale) variables were modeled using multivariable logistic regression and bootstrapping in development and temporal validation cohorts. Baseline inflammatory markers were examined in a subcohort. Results: The year 1 and year 4 development cohorts included 3065 and 2390 patients (mean [SD] age = 64.0 [7.2] years and 63.7 [6.9] years), respectively. Aromatase inhibitor–induced arthralgia occurred in 61.3% of year 1 patients and 66.1% of year 4 patients. Validation cohorts included 1313 year 1 patients and 1009 year 4 patients with similar characteristics. Across models, higher body mass index, greater baseline fatigue, prior articular or muscular disease, chemotherapy exposure, and preexisting pain were associated with subsequent aromatase inhibitor–induced arthralgia; anastrozole use was associated with aromatase inhibitor–induced arthralgia at year 4. The area under the curve was 0.62 to 0.65 in development cohorts and 0.61 to 0.67 in validation cohorts. In the biomarker subcohort (n = 637), higher baseline interleukin 8 level was associated with lower odds of year 1 aromatase inhibitor–induced arthralgia (odds ratio = 0.74, 95% CI = 0.56 to 0.98). Conclusions: Using baseline clinical and patient-reported data, we generated models to identify patients at increased risk of early and persistent aromatase inhibitor–induced arthralgia. Although model performance was modest, risk stratification could help trigger stepped-care pathways to optimize aromatase inhibitor adherence and outcomes. Interleukin 8 association requires independent replication. Trial Registration: ClinicalTrials.gov identifier NCT01993498.

  • Prospective SAJAC Study of Rehabilitation for Adolescents and Young Adults with Cancer in a Comprehensive Cancer Center

    by Emmanuelle Bompas, Audrey Blanc Lapierre, Josselin Sebille, Sophie Allain, Marie Quereau, Solene Wallez, Nelly Soulard, Dominique Berton, Ludovic Doucet, Hélène Senellart, et al.

    Background: Youth patient organizations have taken action to address the specific needs of adolescents and young adults (AYAs), and the third National Cancer Control Plan has made this a requirement. This study presents the center’s rehabilitation program. Patients and Methods: Following initial treatment, patients aged 18–25 were seen annually for 5 years by a multidisciplinary team. Quality of life using the World health organization quality of life (WHOQOL)-BREF and anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) were assessed. The sexologist developed his own scale. The Patients’ Global Impression of Change scale (P-GIC) was used to evaluate patients’ feedback about the program. Results: Forty-five patients were included. The main reason for being unable to work effectively was cancer and/or its treatment for 20 patients out of 23 in activity (87%). Ten patients (22.2%) reported financial difficulties, and 14 patients (31.1%) received support from a social worker. Regarding sexological accompaniment, only 17 patients could be evaluated; most of these patients ( N = 11, 65%) required a sexologist appointment more than a year after the end of their treatment. Regarding psychological support, 44 patients completed the WHOQOL-BREF questionnaire. No particular trend was observed over time. A total of 45 patients completed the HADS. Symptoms of depression may decrease over time, from the end of the treatment to up to 5 years later, whereas anxiety symptoms may not. Of the 48 responses received for the P-GIC satisfaction survey, 43 (89%) indicated satisfaction. Conclusion: The AYA team conducts systematic needs assessment and works to address these needs.

  • Open Access

    Impact of sociality on the circumstances of breast cancer diagnosis

    by Casilda Albert, Lawrence Nadin, François Cherifi, Claire Cheymol, Courèche Kaderbhai, Baptise Sauterey, Olivier Tredan, Florence Lerebours, Catherine Gaudin, Anne-Laure Martin, et al.

    Background: Sociality, including networks and support, influences health outcomes. In breast cancer, socio-economic factors affect screening uptake, but the impact of social isolation and networks on diagnosis pathways remains understudied. This study examines how sociality shapes breast cancer diagnosis circumstances using data from a large national French cohort. Methods: We analyzed 7,316 women aged 50–74 with localized breast cancer from the French CANTO cohort. Sociality was assessed via questionnaire items on relationships, support, and activities. Diagnosis circumstances were classified as screening or clinical examination. Logistic regression models assessed associations, adjusting for clinical, demographic, and socio-economic factors. Internal consistency and construct validity were also evaluated. Results: Women diagnosed by screening (n=5,313) were older, had less advanced disease, higher education and income, and participated more in cultural, social, and religious activities than those diagnosed clinically (n=2,003). After full adjustment, participation in religious/spiritual activities remained the only sociality-related factor significantly associated with diagnosis modality. Higher age, lower comorbidity index and higher income were strongly associated with diagnosis through screening. The items measuring socialty showed low internal consistency; factor analysis identified four sociality dimensions explaining 33% of variance. Conclusions: Clinical factors strongly influence breast cancer diagnosis circumstances. Certain socio-economic and sociality factors, particularly income and religious/spiritual engagement, also shape diagnostic pathways. Weak associations with broader sociality may reflect measurement limitations. Developing precise, context-specific sociality tools could help identify vulnerable women and guide interventions to improve screening uptake and reduce diagnostic disparities.

  • INST’AJA: a co-designed Instagram campaign to promote sexual health education and behaviors in adolescent and young adult cancer survivors

    by Baptiste Sauterey, Pierre Kubicek, Clémence Herrenschmidt, Pauline Pannetier, Amélie Jouan, Léa Moukanas, Solène Deguet, Sibylle D'ARfeuille, Stéphanie Larramendy, Emmanuelle Bompas, et al.

  • Working conditions associated with return to work 2 years after breast cancer: insights from a cohort study

    by Garazi Ruiz de Azua, Idlir Licaj, Sandrine Pinto, Julie Havas, Antonio Di Meglio, Ines Vaz-Luis, Barbara Pistilli, Fabrice André, Anne-Laure Martin, Sibille Everhard, et al.

    Background Work-related determinants of return to work (RTW) after breast cancer (BC) have been poorly studied. Methods We analysed data from 2095 patients with primary BC enrolled in the French multi-center prospective cohort CANTO between 2012 and 2018. We investigated the association between administrative, physical and psychosocial working conditions and RTW two years after diagnosis using Poisson regression with robust variance. All models were adjusted for age, education, having a partner or children, and clinical variables at diagnosis. Analyses stratified by education (up to/higher than high school) and by chemotherapy were conducted. Multiple imputations were performed. Results Having no weekly rest period of 48 consecutive hours (RR = 1.36 95% CI:1.09–1.81), strenuous work postures (RR = 1.48 95% CI:1.19–1.87) and shift work (RR = 1.40 95% CI:1.11–1.75) as well as low independence of decision making (RR = 1.33 95% CI:1.04–1.81) were associated with increased non-RTW. Not perceiving her own job as boring (RR = 0.61 95% CI:0.39–0.86) was associated with decreased non-RTW. Administrative working conditions did not impact RTW. Conclusion Working conditions emerged as potential levers to help women RTW. Our results underline the need for more targeted rehabilitation programs and personalized interventions to effectively help women in their RTW journey after BC.


  • Evaluation of sexual health management practices among general practitioners in Western France: a cross-sectional study

    by Baptiste Sauterey, Clémence Herrenschmidt, Maloù Lec’hVien, Anne Patsouris, Jonathan Allard

  • Open Access

    Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort

    by R. Varnier, D. Pérol, W. Jacot, A. Mailliez, V. Diéras, F. Dalenc, A. Gonçalves, C. Levy, M. Arnedos, J.-S. Frenel, et al.


  • Open Access

    Addressing Akrasia in Childhood, Adolescent and Young Adult Cancer Survivors: Implications for Long-Term Follow-Up and Preventive Health Interventions

    by Charlotte Demoor-Goldschmidt, Kristopher Lamore, Zsuzsanna Jakab, Maëlle de Ville de Goyet, Sabine Heinrich, Laura Bathilde, Claire Berger, Laura Beek, Marion Beauchesne, Erika Borszekine Cserhati, et al.

    Background: Childhood, adolescent, and young adult cancer survivors (CAYACS) face significant long-term health risks, yet adherence to long-term follow-up (LTFU) care remains inconsistent. This study explores the concept of akrasia (i.e., acting against one’s better judgment by engaging in behaviors known to be harmful or counterproductive) to understand the psychological, cognitive, and systemic barriers influencing survivor engagement in LTFU. Method: Using an ethical reflection approach based on a literature review, we discussed survivor experiences, behavioral science insights, and ethical principles to identify solutions that balance patient autonomy with supportive interventions. A narrative approach was used to summarize the key points discussed during the ethics reflection group meetings. Results: Our findings highlight key barriers such as trauma, avoidance behaviors, and cognitive constraints that contribute to non-adherence. Strategies such as shared decision-making, digital health tools, and nudge-based interventions are proposed to enhance survivor engagement. Ethical considerations emphasize the need for personalized and flexible care approaches that respect survivor agency while mitigating obstacles to adherence. Conclusions: Addressing akrasia through ethical and behavioral frameworks could improve LTFU adherence, ultimately enhancing survivorship care and long-term health outcomes.


  • Open Access

    Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort

    by F. Giugliano, A. Bertaut, J. Blanc, A.-L. Martin, C. Gaudin, M. Fournier, A. Kieffer, B. Sauterey, C. Levy, M. Campone, et al.


  • Open Access

    Supplementary Data 1 from Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities

    by Max Piffoux, Jérémie Jacquemin, Mélanie Pétéra, Stéphanie Durand, Angélique Abila, Delphine Centeno, Charlotte Joly, Bernard Lyan, Anne-Laure Martin, Sibille Everhard, et al.

    Supplementary Data 1 from Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities